Frontiers | Clinical Implementation of Precision Oncology Data to Direct Individualized and Immunotherapy-Based Treatment Strategies

Clinical Implementation of Precision Oncology Data to Direct Individualized and Immunotherapy-Based Treatment Strategies

3,387
Total downloads
11k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 24 Dec 2024

The systemic inflammation response index (SIRI) predicts survival in advanced non-small cell lung cancer patients undergoing immunotherapy and the construction of a nomogram model

Chunhan Tang
Min Zhang
Hongyuan Jia
Tianlei Wang
Hongwei Wu
Ke Xu
Tao Ren
Long Liang

doi 10.3389/fimmu.2024.1516737

412 views

ORIGINAL RESEARCH

Published on 23 Dec 2024

Transarterial therapy combined with bevacizumab plus immune checkpoint inhibitors as a neoadjuvant therapy for locally advanced HCC

Zhenyun Yang
Qianyu Wang
Li Hu
Xiaoxian Sima
Juncheng Wang
Dandan Hu
Zhongguo Zhou
Minshan Chen
Yaojun Zhang
Yizhen Fu

doi 10.3389/fimmu.2024.1469302

223 views

ORIGINAL RESEARCH

Published on 20 Dec 2024

Assessing immunotherapy response: going beyond RECIST by integrating early tumor growth kinetics

Mehdi Felfli
Alexandre Thinnes
Sebastien Jacques
Yan Liu
Antoine Iannessi

doi 10.3389/fimmu.2024.1470555

339 views

SYSTEMATIC REVIEW

Published on 03 Dec 2024

Antiangiogenic therapy exerts antitumor effects by altering the tumor microenvironment: bibliometric analysis

Yuan Kang
Yixin Kang
Dianbao Zhang
Jun Yao

doi 10.3389/fimmu.2024.1460533

312 views

CASE REPORT

Published on 02 Dec 2024

Quantification of PD-L1 expression and tumor mutational burden in biologically distinct advanced pancreatic cancers responding to pembrolizumab: case reports

Kevin Y. Li
Andrew M. Lowy
Paul Fanta

doi 10.3389/fimmu.2024.1452543

368 views

SYSTEMATIC REVIEW

Published on 27 Nov 2024

The load of hepatitis B virus reduces the immune checkpoint inhibitors efficiency in hepatocellular carcinoma patients

Zhengzheng Ji
Jiasong Li
Shasha Zhang
Yuanyuan Jia
Jing Zhang
Zhanjun Guo

doi 10.3389/fimmu.2024.1480520

609 views

CASE REPORT

Published on 26 Nov 2024

A surprising complete response to cadonilimab in a primary metastatic cervical cancer: a case report

Haijuan Yu
Jie Lin
Jian Chen
Lijun Chen
Jianping Zou
Bin Liu
Dan Hu
Youping Xiao
Linhao Yu
Yang Sun

doi 10.3389/fimmu.2024.1494138

425 views

MINI REVIEW

Published on 23 Oct 2024

Molecular and modular intricacies of precision oncology

Ravneet Chhabra

doi 10.3389/fimmu.2024.1476494

732 views

ORIGINAL RESEARCH

Published on 26 Sep 2024

Causal effect of thyroid cancer on secondary primary malignancies: findings from the UK Biobank and FinnGen cohorts

Zhengshi Wang
Youlutuziayi Rixiati
Chengyou Jia
Yong Xu
Zhiqiang Yin
Junwen Huang
Jiaqi Dai
Yun Zhang

doi 10.3389/fimmu.2024.1434737

1,132 views

ORIGINAL RESEARCH

Published on 02 Aug 2024

Development and validation of a survival prediction model for patients with advanced non-small cell lung cancer based on LASSO regression

Yimeng Guo
Lihua Li
Keao Zheng
Juan Du
Jingxu Nie
Zanhong Wang
Zhiying Hao

doi 10.3389/fimmu.2024.1431150

1,407 views
1 citation

ORIGINAL RESEARCH

Published on 21 Jun 2024

Real-world comprehensive genomic and immune profiling reveals distinct age- and sex-based genomic and immune landscapes in tumors of patients with non-small cell lung cancer

Zachary D. Wallen
Heidi Ko
Mary K. Nesline
Stephanie B. Hastings
Kyle C. Strickland
Rebecca A. Previs
Shengle Zhang
Sarabjot Pabla
Jeffrey Conroy
7 more
Shakti H. Ramkissoon

doi 10.3389/fimmu.2024.1413956

1,248 views

ORIGINAL RESEARCH

Published on 10 May 2024

The fibrosis-4 index is a prognostic factor for cholangiocarcinoma patients who received immunotherapy

Zhiwei Zhang
Jingzhao Zhang
Ming Cai
Xiaorui Huang
Xinyi Guo
Dengsheng Zhu
Tong Guo
Yahong Yu

doi 10.3389/fimmu.2024.1376590

832 views

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.5 impact factor
- 6.2 citescore

Impact

11kTopic views
7,214Article views
3,387Article downloads

View impact

Submit your idea

Articles

The systemic inflammation response index (SIRI) predicts survival in advanced non-small cell lung cancer patients undergoing immunotherapy and the construction of a nomogram model

Transarterial therapy combined with bevacizumab plus immune checkpoint inhibitors as a neoadjuvant therapy for locally advanced HCC

Assessing immunotherapy response: going beyond RECIST by integrating early tumor growth kinetics

Antiangiogenic therapy exerts antitumor effects by altering the tumor microenvironment: bibliometric analysis

Quantification of PD-L1 expression and tumor mutational burden in biologically distinct advanced pancreatic cancers responding to pembrolizumab: case reports

The load of hepatitis B virus reduces the immune checkpoint inhibitors efficiency in hepatocellular carcinoma patients

A surprising complete response to cadonilimab in a primary metastatic cervical cancer: a case report

Molecular and modular intricacies of precision oncology

Causal effect of thyroid cancer on secondary primary malignancies: findings from the UK Biobank and FinnGen cohorts

Development and validation of a survival prediction model for patients with advanced non-small cell lung cancer based on LASSO regression

Real-world comprehensive genomic and immune profiling reveals distinct age- and sex-based genomic and immune landscapes in tumors of patients with non-small cell lung cancer

The fibrosis-4 index is a prognostic factor for cholangiocarcinoma patients who received immunotherapy

Frontiers in Immunology

Participating Journals

Impact